4.5 Article

Exposure of breast cancer cells to a subcytotoxic dose of apigenin causes growth inhibition, oxidative stress, and hypophosphorylation of Akt

Journal

EXPERIMENTAL AND MOLECULAR PATHOLOGY
Volume 97, Issue 2, Pages 211-217

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yexmp.2014.07.006

Keywords

Apigenin; Breast cancer; Cell cycle; Flavone; Protein kinase B/Akt; Reactive oxygen species

Categories

Funding

  1. Dalhousie Medical Research Foundation
  2. Canadian Breast Cancer Foundation Atlantic Region
  3. Frederick Banting and Charles Best Canada Graduate Scholarship
  4. Canadian Imperial Bank of Commerce Graduate Scholarship
  5. Beatrice Hunter Cancer Research Institute, Terry Fox Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research

Ask authors/readers for more resources

Epidemiological studies show that fruit- and vegetable-rich diets are associated with a reduced risk of developing certain forms of cancer, including breast cancer. In this study we demonstrate that a subcytotoxic concentration of apigenin, which is a flavone found at high concentrations in parsley, onions, grapefruit, oranges, and chamomile tea, inhibited DNA synthesis in a panel of human breast cancer cell lines (MDA-MB-231, MBA-MB-468, MCF-7, SK-BR-3). Decreased proliferation of MDA-MB-468 cells in the presence of apigenin was associated with G(2)/M phase cell cycle arrest and the production of reactive oxygen species. Apigenin-treated MDA-MB-468 cells also showed reduced phosphorylation of Ala (protein kinase B), which is an essential effector serine/threonine kinase in the phosphatidylinositide 3-kinase pathway that promotes tumor growth and progression. However, exposure to the antioxidant reduced glutathione failed to reverse apigenin-mediated inhibition of Akt phosphorylation and cell proliferation, indicating that these effects were not due to oxidative stress. Taken together, these findings suggest that low-dose apigenin has the potential to slow or prevent breast cancer progression. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available